These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 966971

  • 1. Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists.
    Roufogalis BD, Thornton M, Wade DN.
    Life Sci; 1976 Sep 15; 19(6):927-34. PubMed ID: 966971
    [No Abstract] [Full Text] [Related]

  • 2. Factors affecting solubilized dopamine-sensitive adenylate cyclase.
    Marshall AM, Ramwani J, Mishra RK.
    Biochem Pharmacol; 1983 Apr 01; 32(7):1237-41. PubMed ID: 6847713
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of dopamine-sensitive adenylate cyclase in rat striatum by neuroleptic drugs administered in vivo.
    Nakahara T, Uchimura H, Saito M, Hirano M, Kim JS, Ito M.
    J Neurochem; 1978 Nov 01; 31(5):1335-7. PubMed ID: 702178
    [No Abstract] [Full Text] [Related]

  • 4. Regional effects of neuroleptics on dopamine metabolism and dopamine-sensitive adenylate cyclase activity.
    Scatton B, Bischoff S, Dedek J, Korf J.
    Eur J Pharmacol; 1977 Aug 15; 44(4):287-92. PubMed ID: 19266
    [Abstract] [Full Text] [Related]

  • 5. Effects of dopaminergic agonists and antagonists on [3H]apomorphine binding to striatal membranes: sulpiride lack of interactions with positive cooperative [3H]apomorphine binding.
    Fujita N, Saito K, Hirata A, Iwatsubo K, Noguchi Y, Yoshida H.
    Brain Res; 1980 Oct 20; 199(2):335-42. PubMed ID: 7417787
    [Abstract] [Full Text] [Related]

  • 6. Sulpiride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain.
    Trabucchi M, Longoni R, Fresia P, Spano PF.
    Life Sci; 1975 Nov 15; 17(10):1551-6. PubMed ID: 173950
    [No Abstract] [Full Text] [Related]

  • 7. Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats.
    Rotrosen J, Friedman E, Gershon S.
    Life Sci; 1975 Aug 15; 17(4):563-8. PubMed ID: 171534
    [No Abstract] [Full Text] [Related]

  • 8. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.
    Di Chiara G, Porceddu ML, Spano PF, Gessa GL.
    Brain Res; 1977 Jul 15; 130(2):374-82. PubMed ID: 884534
    [No Abstract] [Full Text] [Related]

  • 9. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M, Protais P.
    Neuropharmacology; 1989 Sep 15; 28(9):931-9. PubMed ID: 2554186
    [Abstract] [Full Text] [Related]

  • 10. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV, Roberts S, Hill DF.
    Brain Res; 1975 Aug 22; 94(1):57-66. PubMed ID: 238721
    [Abstract] [Full Text] [Related]

  • 11. Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum.
    Memo M, Lovenberg W, Hanbauer I.
    Proc Natl Acad Sci U S A; 1982 Jul 22; 79(14):4456-60. PubMed ID: 6956874
    [Abstract] [Full Text] [Related]

  • 12. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN, Jenner P, Huizing G, Marsden CD, Miller R.
    Neuropharmacology; 1977 May 22; 16(5):333-42. PubMed ID: 559256
    [No Abstract] [Full Text] [Related]

  • 13. LSD as an agonist and antagonist at central dopamine receptors.
    Von Hungen K, Roberts S, Hill DF.
    Nature; 1974 Dec 13; 252(5484):588-9. PubMed ID: 4431522
    [No Abstract] [Full Text] [Related]

  • 14. Dopamine- and apomorphine-sensitive adenylate cyclase in homogenates of rabbit retina.
    Bucher MB, Schorderet M.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Dec 13; 288(1):103-7. PubMed ID: 169480
    [Abstract] [Full Text] [Related]

  • 15. Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".
    Kebabian JW, Petzold GL, Greengard P.
    Proc Natl Acad Sci U S A; 1972 Aug 13; 69(8):2145-9. PubMed ID: 4403305
    [Abstract] [Full Text] [Related]

  • 16. Subcellular localization of dopamine-sensitive adenylate cyclase in rat brain striatum.
    Laduron P, Verwimp M, Janssen PF, Leysen J.
    Life Sci; 1976 Feb 15; 18(4):433-9. PubMed ID: 130527
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B, Naylor RJ.
    Eur J Pharmacol; 1976 Nov 15; 40(1):9-19. PubMed ID: 791660
    [Abstract] [Full Text] [Related]

  • 18. Dopaminergic mechanisms in the teleost retina. I. Dopamine-sensitive adenylate cyclase in homogenates of carp retina; effects of agonists, antagonists, and ergots.
    Watling KJ, Dowling JE.
    J Neurochem; 1981 Feb 15; 36(2):559-68. PubMed ID: 6109764
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J, Tassin JP, Thierry AM, Glowinski J, Premont J.
    Brain Res; 1977 Feb 11; 122(1):71-86. PubMed ID: 837225
    [Abstract] [Full Text] [Related]

  • 20. Why does sulpiride not block the effect of dopamine on the dopamine-sensitive adenylate cyclase?
    Woodruff GN, Freedman SB, Poat JA.
    J Pharm Pharmacol; 1980 Nov 11; 32(11):802-3. PubMed ID: 6110738
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.